Document is current
Any future updates will be listed below
-
Authors
Rigal, Sophie
Casas, Belén
Kanebratt, Kajsa P.
Wennberg Huldt, Charlotte
Magnusson, Lisa U.
Müllers, Erik https://orcid.org/0000-0002-2176-3248
Karlsson, Fredrik
Clausen, Maryam
Hansson, Sara F.
Leonard, Louise
Cairns, Jonathan https://orcid.org/0000-0002-9982-1401
Jansson Löfmark, Rasmus
Ämmälä, Carina
Marx, Uwe
Gennemark, Peter https://orcid.org/0000-0002-7865-7454
Cedersund, Gunnar
Andersson, Tommy B.
Vilén, Liisa K. https://orcid.org/0000-0001-9184-4847
- License Information
-
More Information
Article History
Received: 18 June 2023
Accepted: 26 June 2024
First Online: 18 July 2024
Competing interests
: K.P.K., C.W.H., L.M., E.M., F.K., M.C., S.F.H., L.L., J.C., R.J.L., P.G., C.Ä., T.B.A., and L.K.V. are employees or previous employees of AstraZeneca. U.M. is a founder, CSO, and shareholder of TissUse GmbH, which commercializes MPS platforms. All other authors declare they have no competing interests.
